The protective effect of percutaneous isolated hepatic perfusion on high-risk group for the recurrence of Hepatocellular carcinoma after resection

肝切除术仍然是提高肝细胞癌（HCC）患者生存率的唯一治疗选择。然而，切除术后复发率高是危及生命的问题。在这项研究中，我们提出了经皮隔离肝灌注（PIHP），一种新的和有效的区域化疗方案，可以实现对肝癌切除术后复发的高危人群的保护。肝切除术后PIHP改善了总生存率。总之，切除和PIHP的双重治疗可以为可切除的HCC治疗提供创新策略。

Hepatic resection remains the only therapeutic option for improved survival in the patients with hepatocellular carcinoma (HCC). However, a high incidence of recurrence after resection is life-threatening problem. In this study, we proposed percutaneous isolated hepatic perfusion (PIHP), a novel and potent regional chemotherapeutic regimen can achieve the protection against high-risk group for the recurrence of HCC after resection. PIHP after hepatic resection improved overall survival. In conclusion, dual treatment of resection and PIHP can offer an innovative strategy for resectable HCC treatment.